E2F1 and hepatocellular carcinoma: Overexpression of FIR in hepatocellular carcinoma (HCC) promotes tumor progression and dedifferentiation by stimulating FBP expression through Transcription Factor DP1/E2F Transcription Factor (TFDP1/E2F1).